市場調査レポート

商品コード

1481417

止血製品の世界市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別- 産業予測、2024年～2031年

Global Hemostasis Products Market Size, Share, Growth Analysis, By Product(Topical Hemostasis Products, Infusible Hemostasis Products), By Application(Trauma, Surgery), By End-user(Hospitals, Clinics) - Industry Forecast 2024-2031

出版日: 2024年05月17日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 811,748円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 949,592円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,087,436円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=153.16円

全表示
概要
目次

概要

サンプル依頼リストに入れる

止血製品の世界市場規模は2022年に16億米ドルと評価され、2023年の16億9,000万米ドルから2031年には25億9,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは5.5%で成長する見通しです。

止血剤市場は、医療技術の向上と意識の高まりにより、世界規模で着実に拡大しています。これらの医薬品は、手術後や外傷後の止血だけでなく、さまざまな出血問題の管理にも不可欠です。止血剤市場は、人口の高齢化、慢性疾患の増加、手術件数の増加によって牽引されています。また、発展途上国におけるヘルスケア施設の利用しやすさも、業界の拡大を後押ししています。さらに、継続的な研究開発努力により、新しい止血製品が発売され、その有効性と安全性が高まっています。しかし、これらの製品は高価であり、規制上の障害もあるため、業界の拡大が阻まれる可能性があります。このような障害にもかかわらず、世界の止血材市場は、ヘルスケアの基準や技術が進歩するにつれて拡大すると予想されます。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主な投資の分析
主な成功要因
競合の程度

市場力学と見通し

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

止血製品の世界市場：製品別

市場概要
局所止血製品
輸液止血製品
高度な止血製品

止血製品の世界市場：用途別

市場概要
トラウマ
手術
血友病
心筋梗塞

止血製品の世界市場：エンドユーザー別

市場概要
病院
クリニック
その他

止血製品の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Johnson & Johnson（US）
Pfizer（US）
Baxter International（US）
Medtronic（US）
B. Braun Melsungen AG（Germany）
Becton, Dickinson, and Company（BD）（US）
Tricol Biomedical（US）
Hemostasis LLC（US）
CuraMedical BV（Netherlands）
Teleflex Incorporated（US）
CryoLife, Inc.（US）
Ethicon, Inc.（US）
Grifols, S.A.（Spain）
Terumo Corporation（Japan）
Integra LifeSciences Holdings Corporation（US）
HemCon Medical Technologies, Inc.（US）
Zimmer Biomet Holdings, Inc.（US）
Haemonetics Corporation（US）
CSL Behring LLC（Australia）
Olympus Corporation（Japan）

Product Code: SQMIG35A2702

Global Hemostasis Products Market size was valued at USD 1.60 billion in 2022 and is poised to grow from USD 1.69 billion in 2023 to USD 2.59 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2024-2031).

The market for hemostasis products is expanding steadily on a global scale as a result of rising awareness and improvements in medical technology. These medicines are essential for managing a variety of bleeding problems as well as for stopping bleeding after surgery and trauma cases. The market for hemostasis products is being driven by an aging population, an increase in chronic diseases, and an increase in surgeries. The growing accessibility of healthcare facilities in developing nations is also fostering industry expansion. In addition, continuous R&D endeavors are resulting in the launch of novel hemostasis products, augmenting their effectiveness and safety. The expensive cost of these items and regulatory obstacles, however, may prevent the industry from expanding. Notwithstanding these obstacles, the market for hemostasis products worldwide is expected to grow as healthcare standards and technologies advance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemostasis Products Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemostasis Products Market Segmental Analysis

The global hemostasis products market is segmented on the basis of product, application, end-user, and region. Based on product, the market is segmented as Topical Hemostasis Product, Infusible Hemostasis Products, and Advanced Hemostasis Products. On the basis of application, the market is segmented into Trauma, Surgery, Hemophilia, Myocardial Infarction. Based on the end-user, it is segregated into hospitals, clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Hemostasis Products Market

The treatment of bleeding problems and surgical operations are being significantly improved by innovations like the development of more environmentally friendly and safe hemostasis products, in addition to hemostatic agents and devices. These upgrades enhance patient outcomes and put pressure on a rise in the market.

Restraints in the Global Hemostasis Products Market

One of the most notable commercial constraints is the high price of hemostasis products. These products may be expensive, which limits their availability to patients in some areas and healthcare facilities with limited funding. The cost factor may prevent the widespread use of better hemostasis solutions, limiting their market penetration and possibly impairing patient care.

Market Trends of the Global Hemostasis Products Market

Both patients and healthcare organizations are looking for less intrusive ways to treat bleeding problems and surgical procedures. This movement makes use of the advancements in progressive hemostasis products and methods, which lessen tissue damage, speed up repair, and improve average patient outcomes. Due to its potential to improve patient comfort and reduce hospital stays, minimally invasive hemostasis techniques are gaining popularity. This trend is in line with the healthcare industry's emphasis on value-based treatment.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Hemostasis Products Market by Product

Market Overview
Topical Hemostasis Products
Infusible Hemostasis Products
Advanced Hemostasis Products

Global Hemostasis Products Market by Application

Market Overview
Trauma
Surgery
Hemophilia
Myocardial Infarction

Global Hemostasis Products Market by End-user

Market Overview
Hospitals
Clinics
and Others

Global Hemostasis Products Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson, and Company (BD) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tricol Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hemostasis LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CuraMedical BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CryoLife, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ethicon, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HemCon Medical Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haemonetics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CSL Behring LLC (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments